Cyclooxygenase inhibitors: From pharmacology to clinical read-outs - ScienceDirect
NSAID - Headache Treatments
Cyclooxygenase Inhibition and Cardiovascular Risk | Circulation
The spectrum of selectivity for COX inhibition: the relative affinities... | Download Scientific Diagram
Nonopioid Analgesics : Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2 Inhibitors, and Acetaminophen | Anesthesia Key
NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? | Journal of Pharmacology and Experimental Therapeutics
Relative COX-2 selectivity of NSAIDS commonly used in the treatment of... | Download Scientific Diagram
Table 1 from The double-edged sword of COX-2 selective NSAIDs. | Semantic Scholar
Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection
Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model | BMC Urology | Full Text
JCI - Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
Full article: Diclofenac: an update on its mechanism of action and safety profile
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs | Semantic Scholar
COX-2 inibitori - Informazioni sui farmaci
Molecules | Free Full-Text | The Impact of Diclofenac Gel on Ion Transport in the Rabbit (Oryctolagus cuniculus) Skin: An In Vitro Study
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis | PNAS
Selective COX-2 inhibitors: Are they safer NSAIDs?
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D1MD00280E
Risks versus Benefits of COX-2-selective NSAIDs - Page 5
COX-2 inibitori - Informazioni sui farmaci
